Literature DB >> 8880070

Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines.

A Mensink1, A Brouwer, E H Van den Burg, S Geurts, W M Jongen, C M Lakemond, I Meijerman, T Van der Wijk.   

Abstract

We recently reported that tumor necrosis factor alpha is able to cause a dose-dependent and persistent reduction in gap junctional intercellular communication between primary human smooth muscle cells. In order to study whether this observed persistent reduction in gap junctional intercellular communication is a unique feature for tumor necrosis factor alpha, the present study focuses on the effects of other growth factors and cytokines on gap junctional intercellular communication. Platelet-derived growth factor AA and BB (PDGF-AA, PDGF-BB), basic fibroblast growth factor (bFGF), interleukin-6 and interferon-gamma were able to modulate gap junctional intercellular communication between primary human smooth muscle cells in vitro. However, our results demonstrate that the magnitude and nature of the observed effects are growth factor- and cytokine-specific. PDGF-AA, PDGF-BB and interleukin-6 caused a transient reduction in gap junctional intercellular communication, while bFGF induced a transient increase in gap junctional intercellular communication. Interferon-gamma was shown to be capable of causing a persistent reduction in gap junctional intercellular communication. In addition, PDGF-AA, PDGF-BB, bFGF, interleukin-6, interferon-gamma and tumor necrosis factor alpha all stimulated smooth muscle cell proliferation. These observations suggest a more complex relationship between modulation of gap junctional intercellular communication and cell proliferation than current hypotheses imply. The implications of the observed effects of growth factors and cytokines on gap junctional intercellular communication between smooth muscle cells in relation to the process of atherosclerosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880070     DOI: 10.1016/0014-2999(96)00368-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis.

Authors:  Wei Cai; Li-ming Ruan; Yi-na Wang; Jun-zhu Chen
Journal:  J Zhejiang Univ Sci B       Date:  2006-08       Impact factor: 3.066

2.  Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway.

Authors:  Guanghong Jia; Gang Cheng; Deepak M Gangahar; Devendra K Agrawal
Journal:  J Mol Cell Cardiol       Date:  2008-03-12       Impact factor: 5.000

3.  Dissection of the molecular basis of pp60(v-src) induced gating of connexin 43 gap junction channels.

Authors:  L Zhou; E M Kasperek; B J Nicholson
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

Review 4.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.